Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
Am J Psychiatry
    October 2024
  1. GALLUCCI J, Yu JC, Oliver LD, Nakua H, et al
    Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
    Am J Psychiatry. 2024;181:910-919.
    >> Share

  2. REILLY TJ, McCutcheon RA
    Menopausal Hormone Therapy for Women With Schizophrenia: What's Stopping Us?
    Am J Psychiatry. 2024;181:854-855.
    >> Share

  3. KRAMER EN, Velicu V
    Aripiprazole Augmentation as a Treatment for Clozapine-Induced Weight Gain.
    Am J Psychiatry. 2024;181:935-936.
    >> Share

  4. CHENGAPPA KNR, Cotes RO
    Clozapine's High Incidence of Ileus and Pneumonia Demand Better Clinical Strategies-How Do We Get There?
    Am J Psychiatry. 2024;181:851-853.
    >> Share

  5. MCINTYRE RS, Kwan ATH, Rosenblat JD, Teopiz KM, et al
    Aripiprazole Augmentation as a Treatment for Clozapine-Induced Weight Gain: Response to Kramer and Velicu.
    Am J Psychiatry. 2024;181:936-937.
    >> Share

  6. HWANG M, Brady R
    Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
    Am J Psychiatry. 2024;181:858-860.
    >> Share

  7. ARNSTEN AFT, Datta D
    Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia.
    Am J Psychiatry. 2024;181:861-864.
    >> Share

  8. TAMMINGA CA
    Psychosis Risk With Prescription Amphetamine.
    Am J Psychiatry. 2024;181:856-857.
    >> Share

  9. KALIN NH
    Schizophrenia Spectrum Disorders and Psychosis.
    Am J Psychiatry. 2024;181:847-850.
    >> Share

  10. LEUCHT S, Priller J, Davis JM
    Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application.
    Am J Psychiatry. 2024;181:865-878.
    >> Share

  11. ARION D, Enwright JF 3rd, Gonzalez-Burgos G, Lewis DA, et al
    Cell Type-Specific Profiles and Developmental Trajectories of Transcriptomes in Primate Prefrontal Layer 3 Pyramidal Neurons: Implications for Schizophrenia.
    Am J Psychiatry. 2024;181:920-934.
    >> Share

    September 2024
  12. PARTANEN JJ, Happola P, Kampe A, Ahola-Olli A, et al
    High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study.
    Am J Psychiatry. 2024 Sep 12:appiajp20230744. doi: 10.1176/appi.ajp.20230744.
    >> Share

  13. MORAN LV, Skinner JP, Shinn AK, Nielsen K, et al
    Risk of Incident Psychosis and Mania With Prescription Amphetamines.
    Am J Psychiatry. 2024 Sep 12:appiajp20230329. doi: 10.1176/appi.ajp.20230329.
    >> Share

  14. BRAND BA, Sommer IE, Gangadin SS, Tanskanen A, et al
    Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder.
    Am J Psychiatry. 2024 Sep 12:appiajp20230850. doi: 10.1176/appi.ajp.20230850.
    >> Share

    July 2024
  15. JONSSON L, Horbeck E, Primerano A, Song J, et al
    Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder.
    Am J Psychiatry. 2024;181:620-629.
    >> Share

    June 2024
  16. KURTZ MM
    Cognitive Remediation in Schizophrenia Spectrum Illness: Evidence for Treatment Persistence.
    Am J Psychiatry. 2024;181:471-473.
    >> Share

  17. VANO LJ, Veronese M, McCutcheon RA, Howes OD, et al
    Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia?
    Am J Psychiatry. 2024;181:468-470.
    >> Share

  18. BRENNAND KJ
    Aligning Stem Cell Models and Postmortem Studies to Query Striatal Neurodevelopment in Schizophrenia.
    Am J Psychiatry. 2024;181:465-467.
    >> Share

  19. BIRNBAUM R, Weinberger DR
    The Genesis of Schizophrenia: An Origin Story.
    Am J Psychiatry. 2024;181:482-492.
    >> Share

  20. KALIN NH
    Advances in Understanding Schizophrenia, ADHD, and ASD.
    Am J Psychiatry. 2024;181:461-464.
    >> Share

  21. TRAMAZZO S, Lian W, Ajnakina O, Carlson G, et al
    Long-Term Course of Remission and Recovery in Psychotic Disorders.
    Am J Psychiatry. 2024;181:532-540.
    >> Share

    May 2024
  22. KANG J, Castro VM, Ripperger M, Venkatesh S, et al
    Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits.
    Am J Psychiatry. 2024 May 15:appiajp20230247. doi: 10.1176/appi.ajp.20230247.
    >> Share

    April 2024
  23. LIGHT GA, Swerdlow NR
    Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?
    Am J Psychiatry. 2024;181:272-274.
    >> Share

    March 2024
  24. VAN DER PLUIJM M, Wengler K, Reijers PN, Cassidy CM, et al
    Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia.
    Am J Psychiatry. 2024 Mar 13:appiajp20220780. doi: 10.1176/appi.ajp.20220780.
    >> Share

  25. VITA A, Barlati S, Ceraso A, Nibbio G, et al
    Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Am J Psychiatry. 2024 Mar 13:appiajp20230396. doi: 10.1176/appi.ajp.20230396.
    >> Share

    February 2024
  26. HOU Y, Xia H, He T, Zhang B, et al
    N2 Responses in Youths With Psychosis Risk Syndrome and Their Association With Clinical Outcomes: A Cohort Follow-Up Study Based on the Three-Stimulus Visual Oddball Paradigm.
    Am J Psychiatry. 2024 Feb 29:appiajp20221013. doi: 10.1176/appi.ajp.20221013.
    >> Share

  27. ROGNLI EB, Hoye A, Bramness JG
    Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.
    Am J Psychiatry. 2024;181:168-169.
    >> Share

  28. ZHU L, Ni T, Guan F
    Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention.
    Am J Psychiatry. 2024;181:168.
    >> Share

    November 2023
  29. SAWADA T, Barbosa AR, Araujo B, McCord AE, et al
    Recapitulation of Perturbed Striatal Gene Expression Dynamics of Donor's Brains With Ventral Forebrain Organoids Derived From the Same Individuals With Schizophrenia.
    Am J Psychiatry. 2023 Nov 2:appiajp20220723. doi: 10.1176/appi.ajp.20220723.
    >> Share

  30. KALIN NH
    New Insights Into Psychotic Disorders.
    Am J Psychiatry. 2023;180:779-781.
    >> Share

  31. VAN DER VEN E, Susser E
    Structural Racism and Risk of Schizophrenia.
    Am J Psychiatry. 2023;180:782-784.
    >> Share

  32. CANNON TD
    Predicting Conversion to Psychosis Using Machine Learning: Are We There Yet?
    Am J Psychiatry. 2023;180:789-791.
    >> Share

  33. GOFF DC, Roffman J, Holt DJ
    Another Step Toward the Prediction of Antipsychotic Treatment Response Using Functional Connectivity.
    Am J Psychiatry. 2023;180:787-788.
    >> Share

  34. FORSYTH JK, Bearden CE
    Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction.
    Am J Psychiatry. 2023;180:792-804.
    >> Share

  35. STRAWBRIDGE RJ, Graham N
    Dissecting the Genetic Relationship Between Schizophrenia and Cardiovascular Disease.
    Am J Psychiatry. 2023;180:785-786.
    >> Share

  36. JOSHI Y, Swerdlow N, Light G
    Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia: Response to Lin and Hsieh.
    Am J Psychiatry. 2023;180:841-842.
    >> Share

    October 2023
  37. SMUCNY J, Davidson I, Carter CS
    Are We There Yet? Predicting Conversion to Psychosis Using Machine Learning.
    Am J Psychiatry. 2023 Oct 4:appiajp20220973. doi: 10.1176/appi.ajp.20220973.
    >> Share

    September 2023
  38. RODEVAND L, Rahman Z, Hindley GFL, Smeland OB, et al
    Characterizing the Shared Genetic Underpinnings of Schizophrenia and Cardiovascular Disease Risk Factors.
    Am J Psychiatry. 2023 Sep 27:appiajp20220660. doi: 10.1176/appi.ajp.20220660.
    >> Share

  39. KUMAR K, Modenato C, Moreau C, Ching CRK, et al
    Subcortical Brain Alterations in Carriers of Genomic Copy Number Variants.
    Am J Psychiatry. 2023;180:685-698.
    >> Share

    August 2023
  40. CAO H, Lencz T, Gallego JA, Rubio JM, et al
    A Functional Connectome-Based Neural Signature for Individualized Prediction of Antipsychotic Response in First-Episode Psychosis.
    Am J Psychiatry. 2023 Aug 30:appiajp20220719. doi: 10.1176/appi.ajp.20220719.
    >> Share

    June 2023
  41. VASSOS E
    What is the Link Between Substance-Induced Psychosis and Primary Psychotic Disorders?
    Am J Psychiatry. 2023;180:404-406.
    >> Share

    May 2023
  42. ROGNLI EB, Heiberg IH, Jacobsen BK, Hoye A, et al
    Transition From Substance-Induced Psychosis to Schizophrenia Spectrum Disorder or Bipolar Disorder.
    Am J Psychiatry. 2023 May 3:appiajp22010076. doi: 10.1176/appi.ajp.22010076.
    >> Share

  43. KALIN NH
    Treatment Issues Related to the Use of Psychedelics, Trichotillomania, Social Anxiety Disorder, Schizophrenia, and Opioid Use Disorder.
    Am J Psychiatry. 2023;180:321-324.
    >> Share

  44. VINOGRADOV S, Meyer-Kalos P
    Treating Pathologies of the Will.
    Am J Psychiatry. 2023;180:331-333.
    >> Share

  45. BUCHANAN RW, Kreyenbuhl J
    An Argument for Antipsychotic Polypharmacy.
    Am J Psychiatry. 2023;180:334-336.
    >> Share

    April 2023
  46. DIENEL SJ, Fish KN, Lewis DA
    The Nature of Prefrontal Cortical GABA Neuron Alterations in Schizophrenia: Markedly Lower Somatostatin and Parvalbumin Gene Expression Without Missing Neurons.
    Am J Psychiatry. 2023 Apr 19:appiajp20220676. doi: 10.1176/appi.ajp.20220676.
    >> Share

  47. JOSHI YB, Molina JL, Braff DL, Green MF, et al
    Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden.
    Am J Psychiatry. 2023 Apr 11:appiajp20220649. doi: 10.1176/appi.ajp.20220649.
    >> Share

  48. ZWICKER A, Fullerton JM, Mullins N, Rice F, et al
    Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected Parents.
    Am J Psychiatry. 2023;180:285-293.
    >> Share

    March 2023
  49. TAIPALE H, Tanskanen A, Tiihonen J
    Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia.
    Am J Psychiatry. 2023 Mar 22:appiajp20220446. doi: 10.1176/appi.ajp.20220446.
    >> Share

  50. REDDY LF, Glynn SM, McGovern JE, Sugar CA, et al
    A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT.
    Am J Psychiatry. 2023 Mar 9:appiajp20220243. doi: 10.1176/appi.ajp.20220243.
    >> Share

  51. HASSERIS S, Albinana C, Vilhjalmsson BJ, Mortensen PB, et al
    Polygenic Risk and Episode Polarity Among Individuals With Bipolar Disorder.
    Am J Psychiatry. 2023;180:200-208.
    >> Share

    January 2023
  52. BANERJEE D, Girirajan S
    Pathogenic Variants and Ascertainment: Neuropsychiatric Disease Risk in a Health System Cohort.
    Am J Psychiatry. 2023;180:11-13.
    >> Share

  53. SHIMELIS H, Oetjens MT, Walsh LK, Wain KE, et al
    Prevalence and Penetrance of Rare Pathogenic Variants in Neurodevelopmental Psychiatric Genes in a Health Care System Population.
    Am J Psychiatry. 2023;180:65-72.
    >> Share

    December 2022
  54. BARBER G, Nemeroff CB, Siegel S
    A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability.
    Am J Psychiatry. 2022;179:892-896.
    >> Share

    November 2022
  55. JONAS KG, Fochtmann LJ, Perlman G, Kane JM, et al
    Distinguishing the Effects of Lead-Time Bias and Duration of Untreated Psychosis.
    Am J Psychiatry. 2022;179:862-863.
    >> Share

  56. SKUSE DH
    Early-Onset Psychosis and Autism Spectrum Disorder: Similar Rates of Deleterious Copy Number Variants, Yet Diverse Phenotypic Manifestations.
    Am J Psychiatry. 2022;179:798-799.
    >> Share

  57. KALIN NH
    Polygenic Risk Scores and Genetics in Psychiatry.
    Am J Psychiatry. 2022;179:781-784.
    >> Share

  58. O'KEEFFE D, Kinsella A, Waddington JL, Clarke M, et al
    Distinguishing the Effects of Lead-Time Bias and Duration of Untreated Psychosis: Reply to Jonas et al.
    Am J Psychiatry. 2022;179:863-864.
    >> Share

  59. SIGSTROM R, Kowalec K, Jonsson L, Clements CC, et al
    Association Between Polygenic Risk Scores and Outcome of ECT.
    Am J Psychiatry. 2022;179:844-852.
    >> Share

    October 2022
  60. SOLMI M, Taipale H, Holm M, Tanskanen A, et al
    Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis.
    Am J Psychiatry. 2022 Oct 6:appiajp21121189. doi: 10.1176/appi.ajp.21121189.
    >> Share

    September 2022
  61. GREGERSEN M, Mollegaard Jepsen JR, Rohd SB, Sondergaard A, et al
    Developmental Pathways and Clinical Outcomes of Early Childhood Psychotic Experiences in Preadolescent Children at Familial High Risk of Schizophrenia or Bipolar Disorder: A Prospective, Longitudinal Cohort Study - The Danish High Risk and Resilience
    Am J Psychiatry. 2022;179:628-639.
    >> Share

  62. COTTER D, Healy C, Staines L, Mongan D, et al
    Broadening the Parameters of Clinical High Risk for Psychosis.
    Am J Psychiatry. 2022;179:593-595.
    >> Share

    August 2022
  63. BROWNSTEIN CA, Douard E, Mollon J, Smith R, et al
    Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder.
    Am J Psychiatry. 2022 Aug 24:appiajp21111175. doi: 10.1176/appi.ajp.21111175.
    >> Share

    June 2022
  64. PAUL SM, Yohn SE, Popiolek M, Miller AC, et al
    Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia.
    Am J Psychiatry. 2022 Jun 27:appiajp21101083. doi: 10.1176/appi.ajp.21101083.
    >> Share

    April 2022
  65. CHAND GB, Singhal P, Dwyer DB, Wen J, et al
    Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population.
    Am J Psychiatry. 2022 Apr 12:appiajp21070686. doi: 10.1176/appi.ajp.21070686.
    >> Share

  66. O'KEEFFE D, Kinsella A, Waddington JL, Clarke M, et al
    20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis.
    Am J Psychiatry. 2022;179:288-297.
    >> Share

  67. CHUNG DW, Geramita MA, Lewis DA
    Synaptic Variability and Cortical Gamma Oscillation Power in Schizophrenia.
    Am J Psychiatry. 2022;179:277-287.
    >> Share

  68. KALIN NH
    Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia.
    Am J Psychiatry. 2022;179:255-258.
    >> Share

  69. MALLA A
    Reducing Duration of Untreated Psychosis: The Neglected Dimension of Early Intervention Services.
    Am J Psychiatry. 2022;179:259-261.
    >> Share

  70. SOHAL VS
    Transforming Discoveries About Cortical Microcircuits and Gamma Oscillations Into New Treatments for Cognitive Deficits in Schizophrenia.
    Am J Psychiatry. 2022;179:267-276.
    >> Share

    March 2022
  71. MANCINI V, Rochas V, Seeber M, Roehri N, et al
    Aberrant Developmental Patterns of Gamma-Band Response and Long-Range Communication Disruption in Youths With 22q11.2 Deletion Syndrome.
    Am J Psychiatry. 2022;179:204-215.
    >> Share

    January 2022
  72. GANESH S, D'Souza DC
    Cannabis and Psychosis: Recent Epidemiological Findings Continuing the "Causality Debate".
    Am J Psychiatry. 2022;179:8-10.
    >> Share

  73. SANCHEZ-RICO M, Limosin F, Hoertel N
    Is a Diagnosis of Schizophrenia Spectrum Disorder Associated With Increased Mortality in Patients With COVID-19?
    Am J Psychiatry. 2022;179:71-73.
    >> Share

    October 2021
  74. KALIN NH
    Depression and Schizophrenia: Sleep, Medical Risk Factors, Biomarkers, and Treatment.
    Am J Psychiatry. 2021;178:881-884.
    >> Share

  75. CANNON TD
    Do the Benefits of Early Intervention Services for Psychosis Generalize and Persist in the Real World?
    Am J Psychiatry. 2021;178:890-892.
    >> Share

    September 2021
  76. KALIN NH
    Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities.
    Am J Psychiatry. 2021;178:779-782.
    >> Share

    August 2021
  77. PARKER DA, Trotti RL, McDowell JE, Keedy SK, et al
    Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features.
    Am J Psychiatry. 2021 Aug 19:appiajp202120071043.
    >> Share

    July 2021
  78. POSSELT CM, Albert N, Nordentoft M, Hjorthoj C, et al
    The Danish OPUS Early Intervention Services for First-Episode Psychosis: A Phase 4 Prospective Cohort Study With Comparison of Randomized Trial and Real-World Data.
    Am J Psychiatry. 2021 Jul 28:appiajp202120111596.
    >> Share

  79. WEISER M, Davis JM, Brown CH, Slade EP, et al
    Differences in Antipsychotic Treatment Discontinuation Among Veterans With Schizophrenia in the U.S. Department of Veterans Affairs.
    Am J Psychiatry. 2021 Jul 14:appiajp202020111657.
    >> Share

  80. MARDER SR
    Changing the Face of Schizophrenia.
    Am J Psychiatry. 2021;178:584-585.
    >> Share

    May 2021
  81. JOSHI YB, Thomas ML, Braff DL, Green MF, et al
    Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Am J Psychiatry. 2021 May 14:appiajp202020081212.
    >> Share

  82. ANGLIN DM, Ereshefsky S, Klaunig MJ, Bridgwater MA, et al
    From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States.
    Am J Psychiatry. 2021 May 3:appiajp202020071091.
    >> Share

  83. HONER WG
    Better Evidence for Pharmacological Maintenance Treatment in Nonaffective Psychoses: Implications for Relapse Prevention.
    Am J Psychiatry. 2021;178:369-371.
    >> Share

  84. FERRARELLI F, Phillips ML
    Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments.
    Am J Psychiatry. 2021;178:400-413.
    >> Share

    April 2021
  85. AMSALEM D, Markowitz JC, Jankowski SE, Yang LH, et al
    Sustained Effect of a Brief Video in Reducing Public Stigma Toward Individuals With Psychosis: A Randomized Controlled Trial of Young Adults.
    Am J Psychiatry. 2021 Apr 26:appiajp202020091293.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016